Intranasal vaccination of rabbits with Pasteurella multocida A:3 outer membranes that express iron-regulated proteins

Anthony W. ConferDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

Search for other papers by Anthony W. Confer in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Mark A. SuckowLaboratory Animal Program, Office of Vice President for Research, Purdue University, West Lafayette, IN 47907.
Present address is Freimann Life Sciences Center, University of Notre Dame, Notre Dame, IN 46556.

Search for other papers by Mark A. Suckow in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Marie MontelongoDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

Search for other papers by Marie Montelongo in
Current site
Google Scholar
PubMed
Close
 BS
,
S. Mady DaboDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

Search for other papers by S. Mady Dabo in
Current site
Google Scholar
PubMed
Close
 PhD
,
Lawrence J. MiloscioLaboratory Animal Program, Office of Vice President for Research, Purdue University, West Lafayette, IN 47907.

Search for other papers by Lawrence J. Miloscio in
Current site
Google Scholar
PubMed
Close
 BS
,
Arden J. GillespieDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

Search for other papers by Arden J. Gillespie in
Current site
Google Scholar
PubMed
Close
 BS
, and
Glacia L. MeredithDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078.

Search for other papers by Glacia L. Meredith in
Current site
Google Scholar
PubMed
Close
 MS
View More View Less

Abstract

Objective—To determine efficacy of intranasal vaccination of rabbits with Pasteurella multocida A:3 outer membrane proteins (OMP) expressing iron-regulated OMP (IROMP) in conferring protection against experimental challenge exposure.

Animals—52 male New Zealand White rabbits.

Procedure— Rabbits were vaccinated intranasally on days 0, 7, and 14; some vaccines included cholera toxin (CT) as an adjuvant. Concentrations of intranasal IgA and serum IgG antibodies against P multocida OMP were determined. In experiment A, rabbits were vaccinated with either phospate-buffered saline solution (PBSS), PBSS-CT, OMP-CT, or IROMP-CT, challenge-exposed intranasally on day 16, and euthanatized and necropsied on day 28. Rabbits were also vaccinated with OMP or IROMP without CT and were not challenge-exposed. In experiment B, rabbits were vaccinated with PBSS, PBSS-CT, IROMP, or IROMP-CT. On day 17, rabbits were challenge-exposed intranasally .Nasal bacteria and antibodies were determined on day 24.

Results—In experiment A, OMP-CT vaccination stimulated mucosal and systemic antibody responses to the bacterium and enhanced resistance against challenge exposure. Intranasal bacterial counts were not significantly reduced. Vaccination with IROMP-CT stimulated mucosal and systemic antibodies, enhanced resistance to challenge exposure, and significantly reduced nasal bacterial counts. In experiment B, natural infection was detected in several rabbits at challenge exposure; however, IROMP-CT-vaccinated rabbits had significantly higher serum and nasal antibody responses, compared with other rabbitsIROMP-CT-vaccinated rabbits had significantly lower nasal bacterial counts compared to control rabbits.

Conclusions and Clinical Relevance—Intranasal vaccination of rabbits with P multocida outer membranes containing IROMP and CT stimulated immunity against experimental pneumonic pasteurellosis. (Am J Vet Res 2001;62:697–703)

Abstract

Objective—To determine efficacy of intranasal vaccination of rabbits with Pasteurella multocida A:3 outer membrane proteins (OMP) expressing iron-regulated OMP (IROMP) in conferring protection against experimental challenge exposure.

Animals—52 male New Zealand White rabbits.

Procedure— Rabbits were vaccinated intranasally on days 0, 7, and 14; some vaccines included cholera toxin (CT) as an adjuvant. Concentrations of intranasal IgA and serum IgG antibodies against P multocida OMP were determined. In experiment A, rabbits were vaccinated with either phospate-buffered saline solution (PBSS), PBSS-CT, OMP-CT, or IROMP-CT, challenge-exposed intranasally on day 16, and euthanatized and necropsied on day 28. Rabbits were also vaccinated with OMP or IROMP without CT and were not challenge-exposed. In experiment B, rabbits were vaccinated with PBSS, PBSS-CT, IROMP, or IROMP-CT. On day 17, rabbits were challenge-exposed intranasally .Nasal bacteria and antibodies were determined on day 24.

Results—In experiment A, OMP-CT vaccination stimulated mucosal and systemic antibody responses to the bacterium and enhanced resistance against challenge exposure. Intranasal bacterial counts were not significantly reduced. Vaccination with IROMP-CT stimulated mucosal and systemic antibodies, enhanced resistance to challenge exposure, and significantly reduced nasal bacterial counts. In experiment B, natural infection was detected in several rabbits at challenge exposure; however, IROMP-CT-vaccinated rabbits had significantly higher serum and nasal antibody responses, compared with other rabbitsIROMP-CT-vaccinated rabbits had significantly lower nasal bacterial counts compared to control rabbits.

Conclusions and Clinical Relevance—Intranasal vaccination of rabbits with P multocida outer membranes containing IROMP and CT stimulated immunity against experimental pneumonic pasteurellosis. (Am J Vet Res 2001;62:697–703)

Advertisement